Pharmacogenomic architecture of attention deficit/hyperactivity disorder in Latin-American subjects

Key Points

• Pharmacogenomics reveals specific genetic variants linked to attention deficit hyperactivity disorder.
• Key evidence shows that genetic factors contribute to ADHD among Latin-American subjects, emphasizing diversity in genetic architecture.
• This analysis identifies biomarkers related to drug response, providing insights for future treatment strategies.
• Findings support personalized medicine approaches in ADHD management, calling for more studies in diverse populations.